We are live on
!
Find out more
HWA
HCR Wealth Advisors Portfolio holdings
AUM
$1.12B
1-Year Est. Return
33.13%
This Fund
S&P 500
This Quarter
Est. Return
+10.55%
1 Year Est. Return
+33.13%
3 Year Est. Return
+90.97%
5 Year Est. Return
+118.97%
10 Year Est. Return
–
AUM
$437M
AUM Growth
+$11.2M
(+2.6%)
Cap. Flow
-$24.6M
Cap. Flow
% of AUM
-5.63%
Top 10 Holdings %
Top 10 Hldgs %
55.05%
Holding
263
New
17
Increased
85
Reduced
58
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$7.87M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$4.46M |
| 3 |
AutoNation
AN
|
+$3.49M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$2.99M |
| 5 |
First Trust Preferred Securities and Income ETF
FPE
|
+$2.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$28.4M |
| 2 |
ProShares Short S&P500
SH
|
+$15.6M |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$7.03M |
| 4 |
ProShares Short QQQ
PSQ
|
+$3.39M |
| 5 |
Amazon
AMZN
|
+$933K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.86% |
| 2 | Consumer Discretionary | 7.33% |
| 3 | Communication Services | 6.18% |
| 4 | Financials | 5.72% |
| 5 | Consumer Staples | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
iShares Core MSCI Total International Stock ETF
IXUS
$58.4B
| – | – |
-1,831
| Closed | -$101K |
|
252
Eli Lilly
LLY
$1.02T
| – | – |
-1,329
| Closed | -$217K |
|
253
Moleculin Biotech
MBRX
$2.94M
| – | – |
-7
| Closed | -$14K |
|
254
Magnite
MGNI
$2.77B
| – | – |
-34,799
| Closed | -$231K |
|
255
Paycom
PAYC
$7.64B
| – | – |
-634
| Closed | -$203K |
|
|
PPBT
256
Purple Biotech
PPBT
$1.29M
| – | – |
-10
| Closed | -$18K |
|
257
Phillips 66
PSX
$84.9B
| – | – |
-3,033
| Closed | -$215K |
|
258
Schwab US Broad Market ETF
SCHB
$43.2B
| – | – |
-408
| Closed | -$5K |
|
259
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| – | – |
-18
| Closed | -$1K |
|
260
Tenax Therapeutics
TENX
$387M
| – | – |
-10
| Closed | -$14K |
|
261
iShares MSCI USA Value Factor ETF
VLUE
$9.21B
| – | – |
-20
| Closed | -$1K |
|
262
Verastem
VSTM
$489M
| – | – |
-833
| Closed | -$17K |
|
263
cbdMD
YCBD
$5.36M
| – | – |
-56
| Closed | -$38K |
|
Similar funds
CNC
MTCM
AIM
C
FLAM
CT
SL
RIM
HCR Wealth Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, HCR Wealth Advisors held 263 positions worth $437M, up 2.6% from $426M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
HCR Wealth Advisors withdrew a net $24.6M in Q3 2020, closing 23 positions and reducing 58 holdings. Its most notable exit was Idexx Laboratories, an estimated $241K position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, HCR Wealth Advisors opened a new position in AutoNation worth $3.57M.
- HCR Wealth Advisors's largest Q3 2020 buy was AutoNation: 67,028 shares worth $3.57M.
- HCR Wealth Advisors added most to Vanguard High Dividend Yield ETF in Q3 2020, an estimated $7.87M increase.
- HCR Wealth Advisors's biggest Q3 2020 reduction was Apple, cutting an estimated $28.4M.
- HCR Wealth Advisors fully exited Idexx Laboratories in Q3 2020, selling an estimated $241K.
- HCR Wealth Advisors's ten largest holdings make up 55% of its $437M portfolio in Q3 2020.
- HCR Wealth Advisors opened 17 new positions and closed 23 in Q3 2020.
- HCR Wealth Advisors's portfolio value rose 2.6% quarter-over-quarter to $437M.
Based on HCR Wealth Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.